FilingReader Intelligence
Sunflower Pharmaceutical receives regulatory acceptance for vitamin drops
July 16, 2025 at 10:51 AM UTC•By FilingReader AI
Sunflower Pharmaceutical Group announced that its subsidiary received an acceptance notice from the National Medical Products Administration for its Vitamin K1 Drops.
The product is intended for preventing vitamin K deficiency bleeding in infants and is classified as a Class 3 chemical medicine. The acceptance initiates the review and approval process for market authorization.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002737•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Sunflower Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime